Comparative pharmacokinetics of oxytetracycline in tilapia (Oreochromis spp.) maintained at three different salinities

作者: Pritam K. Sidhu , Stephen A. Smith , Corinne Mayer , Geraldine Magnin , David D. Kuhn

DOI: 10.1016/J.AQUACULTURE.2018.06.044

关键词:

摘要: Abstract Environmental factors, such as temperature, pH, and salinity of water may affect the pharmacokinetics (PK) a drug in aquatic animals most instances is ignored PK studies. This study compared profiles oxytetracycline (OTC) following single oral dosage 50 mg/kg tilapia (Oreochromis spp.) maintained three environments: freshwater (FW: 0 ppt salinity), brackish (BW: 15 ppt salinity) salt (SW: 30 ppt salinity). Water quality parameters between systems were similar except salinity. Following OTC administration, blood samples collected at 23 time points: 0.25, 0.5, 1, 2, 4, 6, 9, 12, 24 h, 8, 10, 14, 18, 22, 26, 30, 34, 38 42 days. At each sampling time, six fish from group netted, sedated with buffered MS-222, bled then euthanized. The was extracted plasma by Solid Phase Extraction (SPE) analyzed Ultra High Pressure Liquid Chromatography coupled tandem quadrupole mass spectrometer. concentration versus data for FW, BW SW subjected to analysis using non-compartment methods. Pharmacokinetics characterized rapid absorption slow excretion FW tilapia. Compared groups, elimination faster AUC0-∞ order (165 h.μg/mL) > BW (145 h.μg/mL) > SW (55.5 h.μg/mL) group. In tilapia, terminal half-life (69 h) >2 times shorter than (177 h) (155 h) groups. However, AUCs half-lives groups not significantly different. indicated that rise level increases clearance It suggested residues tissues will be same different levels. results confirmed infectious diseases associated bacteria having MIC 0.5–1.0 μg/mL can treated group, but lead therapeutic failure increased risk resistance emergence.

参考文章(40)
Peter R. Smith, Alain Le Breton, Tor Einar Horsberg, Flavio Corsin, Guidelines for Antimicrobial Use in Aquaculture Guide to antimicrobial use in animals. pp. 207- 218 ,(2009) , 10.1002/9781444302639.CH12
Pierre-Louis Toutain, Aude Ferran, Alain Bousquet-Mélou, Species Differences in Pharmacokinetics and Pharmacodynamics Handbook of experimental pharmacology. pp. 19- 48 ,(2010) , 10.1007/978-3-642-10324-7_2
C. Y. Chen, R. G. Getchell, G. A. Wooster, A. L. Craigmill, P. R. Bowser, Oxytetracycline Residues in Four Species of Fish after 10-Day Oral Dosing in Feed Journal of Aquatic Animal Health. ,vol. 16, pp. 208- 219 ,(2004) , 10.1577/H04-071.1
P. Sidhu, A. Rassouli, J. Illambas, T. Potter, L. Pelligand, A. Rycroft, P. Lees, Pharmacokinetic–pharmacodynamic integration and modelling of florfenicol in calves Journal of Veterinary Pharmacology and Therapeutics. ,vol. 37, pp. 231- 242 ,(2014) , 10.1111/JVP.12093
Michiel Onne Elema, Kjell Arne Hoff, Henning Gjelstrup Kristensen, Bioavailability of oxytetracycline from medicated feed administered to Atlantic salmon (Salmo salar L.) in seawater Aquaculture. ,vol. 143, pp. 7- 14 ,(1996) , 10.1016/0044-8486(96)01253-7
G Rigos, Tyrpenou, I Nengas, A.E.M Alexis, F Athanassopoulou, G.M Troisi, Poor bioavailability of oxytetracycline in sharpsnout sea bream Diplodus puntazzo Aquaculture. ,vol. 235, pp. 489- 497 ,(2004) , 10.1016/J.AQUACULTURE.2003.10.016